Linking angiogenesis to bone destruction in arthritis
Open Access
- 5 May 2005
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (5) , 1346-1348
- https://doi.org/10.1002/art.21015
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Gene therapy targeting the Tie2 function ameliorates collagen‐induced arthritis and protects against bone destructionArthritis & Rheumatism, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Physiologic responses to hypoxia and implications for hypoxia‐inducible factors in the pathogenesis of rheumatoid arthritisArthritis & Rheumatism, 2004
- Angiostatin Inhibits Bone Metastasis Formation in Nude Mice through a Direct Anti-osteoclastic ActivityJournal of Biological Chemistry, 2003
- Vascular Endothelial Growth Factor Up-regulates Expression of Receptor Activator of NF-κB (RANK) in Endothelial CellsJournal of Biological Chemistry, 2003
- Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor α–induced angiogenesis in rheumatoid arthritisArthritis & Rheumatism, 2003
- Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor αAnnals of the Rheumatic Diseases, 2003
- Angiostatin gene transfer as an effective treatment strategy in murine collagen‐induced arthritisArthritis & Rheumatism, 2002
- Neutralization of Vascular Endothelial Growth Factor Prevents Collagen-Induced Arthritis and Ameliorates Established Disease in MiceBiochemical and Biophysical Research Communications, 2001
- Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human OsteoclastogenesisJournal of Biological Chemistry, 2001